Shadow Foundr
3
1M
2
0.33
- Stages of investment
- Areas of investment
Summary
The fund is constantly included in less than 2 deals per year. The usual things for fund are deals in the range of 1 - 5 millions dollars. The important activity for fund was in 2019.
Among the most popular fund investment industries, there are Industrial Manufacturing, Pharmaceutical. Among the various public portfolio startups of the fund, we may underline LIfT BioSciences Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund.
The usual cause for the fund is to invest in rounds with 2 partakers. Despite the Shadow Foundr, startups are often financed by Northern Powerhouse Investment Fund, Horizon 2020, Cambridge Angels group. The meaningful sponsors for the fund in investment in the same round are Mercia Technologies, KIZOO, Envestors. In the next rounds fund is usually obtained by KIZOO.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 0
- Follow on index
- 0.33
- Investments by industry
- Biopharma (2)
- Health Care (2)
- Life Science (2)
- Pharmaceutical (2)
- Biotechnology (2) Show 4 more
- Investments by region
-
- United Kingdom (3)
- Peak activity year
- 2019
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Group Appearance index
- 0.67
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| LIfT BioSciences | 14 Aug 2019 | Biotechnology, Health Care, Medical, Life Science, Pharmaceutical, Biopharma | Early Stage Venture | 2M | England, London, United Kingdom |
Similar funds
By same location
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.